Chair and chief executive, McKesson
Appears in 2 stories
Leading McKesson's oncology and specialty services strategy
The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.
Updated Aug 26
Appointed interim chair, May 26, 2026
BP's board removed chair Albert Manifold on Tuesday, eight months after he took the role. London-listed shares fell as much as 9%. Directors cited serious concerns about governance standards, oversight and conduct.
Updated May 26
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
